The quadrivalent vaccine is recommended at age 33.
There are currently three types of HPV vaccines on the market, including the Septavalent, Quadrivalent and Bivalent vaccines. The nine-valent vaccine can prevent nine types of HPV viruses, which is the vaccine with the widest coverage, but the age of vaccination for the nine-valent vaccine is 16-26 years old, and 33 years old is already over the age of vaccination for the nine-valent, so it is recommended to receive the quadrivalent vaccine.
The quadrivalent vaccine prevents four types of HPV infections, preventing the high-risk viruses HPV16 and HPV18, and the low-risk viruses HPV6 and HPV11, and is effective in stopping most cervical cancers and genital warts.
Although the quadrivalent vaccine has less coverage compared to the Septavalent, its vaccination age is 9-45 years old, which makes it a good choice for those who are older than the age for the Septavalent vaccine.
For the cervical cancer vaccine, whether it’s the Septavalent, Quadrivalent or Bivalent, getting vaccinated early is key.